Joint research on an artificial intelligence model to support the treatment of atrial fibrillation
First written in FY2022-Q3. 1 of 2 entries say "Restated". Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022RestatedAnnual report
「The company commenced joint research with National University Corporation Kyushu University on the development of an artificial intelligence model that proposes expert treatment for percutaneous catheter myocardial ablation in atrial fibrillation.」
The disclosure continues to report the commencement of joint research with Kyushu University and selection for an AMED-related project. - FY2022-Q3First statedAnnual report
「The company commenced joint research with National University Corporation Kyushu University on the development of an artificial intelligence model that proposes expert treatment for percutaneous catheter myocardial ablation in atrial fibrillation. This joint research was selected for the Practical Research Project for Cardiovascular Disease, Diabetes and Other Lifestyle-Related Diseases in cooperation with the Medical Arts Research Project for fiscal 2021 of the Japan Agency for Medical Research and Development, a National Research and Development Agency.」
The commencement of joint research with Kyushu University and selection for an AMED-related project were disclosed.